With reference to announcement no. 18, 2013, the European Patent Office (EPO)
has set a new date for the processing of the appeal concerning rejection of
BioPorto’s NGAL cutoff patent, issued in Europe. The change of date is at the
request of Abbott, one of the opponents in the case. 

The case will be set at the EPO Boards of Appeal on October 15, 2013.



For further information, please contact:

Christina Thomsen, Investor Relations

Thea Olesen, CEO

Tel. +45 4529 0000, e-mail investor@bioporto.com